Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Xu, Huanbai ^a,b   Wu, Qiong ^a   Dang, Shipeng ^a   Jin, Min ^a   Xu, Jingwei ^a   Cheng, Yiji ^a   Pan, Minglin ^c   Wu, Yugang ^a,d   Zhang, Chunhui ^a   Zhang, Yanyun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BENGBU MEDICAL COLLEGE   (China)

^c THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR7; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIAL PROTEIN 2; TOLL LIKE RECEPTOR 4; TUMOR PROTEIN; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR CXCR; CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; CXCR7 PROTEIN, HUMAN; PROTEIN MD 2; TLR4 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISTANT METASTASIS; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; LYMPH NODE METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR CELL; TUMOR GROWTH; TUMOR PROMOTION; TUMOR VOLUME; CELL MOTION; COLORECTAL TUMOR; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIPOPOLYSACCHARIDES; LYMPHATIC METASTASIS; LYMPHOCYTE ANTIGEN 96; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, CXCR; RECEPTORS, CXCR4; TOLL-LIKE RECEPTOR 4; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 83355173190     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027399     Document Type: Article

References (28)

1. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, et al. (2001) Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 167: 1609-16.
2. Rao VP, Poutahidis T, Ge Z, Nambiar PR, Boussahmain C, et al. (2006) Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 66: 7395-400.
3. Gunter MJ, Stolzenberg-Solomon R, Cross AJ, Leitzmann MF, Weinstein S, et al. (2006) A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 66: 2483-7.
4. Doan HQ, Bowen KA, Jackson LA, Evers BM, (2009) Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells. Anticancer Res 29: 2473-8.
5. Otte JM, Cario E, Podolsky DK, (2004) Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126: 1054-70.
6. Strus M, Gosiewski T, Fyderek K, Wedrychowicz A, Kowalska-Duplaga K, et al. (2009) A role of hydrogen peroxide producing commensal bacteria present in colon of adolescents with inflammatory bowel disease in perpetuation of the inflammatory process. J Physiol Pharmacol 60 (Suppl 6): 49-54.
7. Cario E, Gerken G, Podolsky DK, (2004) Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127: 224-38.
8. Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, et al. (2007) Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133: 1869-81.
9. Hausmann M, Kiessling S, Mestermann S, Webb G, Spottl T, et al. (2002) Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122: 1987-2000.
10. Santin I, Castellanos-Rubio A, Hualde I, Castano L, Vitoria JC, et al. (2007) Toll-like receptor 4 (TLR4) gene polymorphisms in celiac disease. Tissue Antigens 70: 495-8.
11. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, et al. (2004) Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53: 987-92.
12. Zhao C, Lu X, Bu X, Zhang N, Wang W, (2010) Involvement of tumor necrosis factor-alpha in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori. BMC Cancer 10: 419.
13. Tarnowski M, Grymula K, Reca R, Jankowski K, Maksym R, et al. (2010) Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas. Mol Cancer Res 8: 1-14.
14. Dong C, Slattery MJ, Liang S, Peng HH, (2005) Melanoma cell extravasation under flow conditions is modulated by leukocytes and endogenously produced interleukin 8. Mol Cell Biomech 2: 145-59.
15. Muller A, Homey B, Soto H, Ge N, Catron D, et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-6.
16. Thuringer D, Hammann A, Benikhlef N, Fourmaux E, Bouchot A, et al. (2011) Transactivation of the epidermal growth factor receptor by heat shock protein 90 via Toll-like receptor 4 contributes to the migration of glioblastoma cells. J Biol Chem 286: 3418-28.
17. Gonzalez-Reyes S, Marin L, Gonzalez L, Gonzalez LO, del Casar JM, et al. (2010) Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC Cancer 10: 665.
18. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, et al. (2002) Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3: 667-72.
19. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, et al. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-52.
20. Kim HM, Park BS, Kim JI, Kim SE, Lee J, et al. (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130: 906-17.
21. Kim TW, Staschke K, Bulek K, Yao J, Peters K, et al. (2007) A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J Exp Med 204: 1025-36.
22. Yamamoto M, Yamazaki S, Uematsu S, Sato S, Hemmi H, et al. (2004) Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 430: 218-22.
23. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, et al. (2004) RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 5: 503-7.
24. O'Hayre M, Salanga CL, Handel TM, Allen SJ, (2008) Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 409: 635-49.
25. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, et al. (2005) The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280: 35760-6.
26. Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, et al. (2007) CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci U S A 104: 15735-40.
27. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, et al. (2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203: 2201-13.
28. Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, et al. (2010) Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc Natl Acad Sci U S A 107: 628-32.